Power Outage Apr2021 Covid-19 Vaccines, CanSino, Sinopharm Sinovac, Covovax, Covax, Novavax, CanSino, Johnson Janssen, Gamaleya Sputnik V, AstraZenica Oxford, Pfizer, Moderna, Bharat Biotech

Healthcare workers remain a key high-risk
group and regular testing was introduced
for patient-facing staff at the end of
last year to help protect primary care
workers and curb the potential spread of
COVID-19.
David Rolfe, CEO Althea said: “As
COVID-19 continues to spread, and while
vaccinations are being rolled out, testing
remains crucial to contain the spread of
COVID-19. We are pleased to be able
to offer the Roche rapid antigen tests to
support those providing vital services
across the country with a reliable, highquality
testing option at an affordable
price. At a time where budgets are
stretched and health services are under
pressure, as a trusted partner to many
hospitals in the UK, we want to do our
part in supporting those working on the
frontline.”
Althea has been a trusted partner for the
acute healthcare sector for the last 20 years.
The company manages and maintains
medical technology in hospitals and is entirely
vendor-independent, meaning they can
combine the best technology from across all
manufacturers. At a time when healthcare
providers are facing unprecedented demand,
the company aims to support hospitals with
increased capacity and new technology
delivered in the most cost effective and
clinically effective way.
During COVID-19, Althea played a key role
in setting up equipment at the London NHS
Nightingale Hospital which was set up to
administer emergency care to COVID-19
patients. Today the company are providing
rapid COVID-19 tests to help further support
the national response to COVID-19.
Roche’s SARS-CoV-2 Rapid Antigen Test is
a rapid chromatographic immunoassay and
is performed using a nasopharyngeal swab.
The test has a sensitivity of 96.52% and a
specificity of 99.68%.
85